(Q80223567)
Statements
Concomitant use of gastric acid-reducing agents is frequent among HIV-1-infected patients receiving protease inhibitor-based highly active antiretroviral therapy (English)
van Lunzen J
Liess H
Arastéh K
Walli R
Daut B